Sign in
4

Changes in Ownership

Outlook Therapeutics, Inc. Filed Acc 0001209191-23-004732

Chief Commercial Officer sold 267,000 shares at $1.11 ($296,370)

From the SEC's structured data for this filing

Trades in this filing

Evanson Jeff · Chief Commercial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-01-20 Sale : show line 1 in the form −267,000 $1.11 $296,370 745,975 D
Open-market sales · 267,000 sh · avg $1.11 · $296,370
Loading xslF345X03/doc4.xml…